Ken Griffin Elanco Animal Health Inc Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$14.37 - $16.46 $155,196 - $177,768	10,800 Added 6.16%	186,100 $3.03 Million
Q4 2023 Feb 14, 2024	SELL	$8.6 - $14.94 $194,360 - $337,644	-22,600 Reduced 11.42%	175,300 $2.61 Million
Q3 2023 Nov 14, 2023	BUY	$9.81 - $12.62 $410,058 - $527,516	41,800 Added 26.78%	197,900 $2.22 Million
Q2 2023 Aug 14, 2023	SELL	$8.08 - $10.37 $725,584 - $931,225	-89,800 Reduced 36.52%	156,100 $1.57 Million
Q1 2023 May 15, 2023	SELL	$8.79 - $14.58 $196,895 - $326,592	-22,400 Reduced 8.35%	245,900 $2.31 Million

Q4 2022 Feb 14, 2023	SELL	$11.49 - $13.65 $592,884 - $704,340	-51,600 Reduced 16.13%	268,300 $3.28 Million
Q3 2022 Nov 14, 2022	BUY	$12.41 - $32.42 $2.5 Million - $6.52 Million	201,100 Added 169.28%	319,900 $3.97 Million

407

473M

2.6M

916K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.64B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.